Because glucocorticoid-induced osteoporosis (GIOP) is becoming a more common issue in rheumatology practice, it is important for rheumatologists to understand anabolic and antiresorptive agents for treating GIOP. Would you prescribe anabolic therapy or antiresorptive agents as first-line treatment for patients with GIOP?
Rheumatology and Arthritis Learning Network® is an online resource for the latest developments in rheumatology practice, providing a customized experience for readers to stay informed about the topics that matter most to them.
Upadacitinib Shows Positive Results in Clinical Trials for AS, nr-axSpA
Late-Breaking Results from Phase 3 Trials of Risankizumab